Memorial Sloan Kettering Cancer Center
Genitourinary
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment of Patients With Advanced ccRCC"
FEATURING
Martin Voss
- 124 views
- November 24, 2023
University of Colorado Cancer Center
Theranostics and the Changing Face of Prostate Cancer
FEATURING
Michael Morris
- 236 views
- October 21, 2022
Memorial Sloan Kettering Cancer Center
Results of Phase II Clinical Trial of Cabozantinib + Nivolumab for Advanced ncRCC
FEATURING
Chung-Han Lee
- 65 views
- April 26, 2022
- 1
ecancer
ASCO 2021 Update on mCRPC: VISION Trial Data on Lutetium-177-PSMA-617
FEATURING
Michael Morris
- 27 views
- September 2, 2021
- 1